It is expected that the fermentation of RS to short-chain fatty acids (SCFA) will influence satiety hormones (GLP-1 and PYY) [24,25] and lower the risk of developing obesity and metabolic signs of MetS [26,27,28]. The gene discussed is PYY; the disease is metabolic syndrome.